Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

ASNDASND
Showing 7 of 21 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in ASCENDIS PHARMA A/S

FARALLON CAPITAL MANAGEMENT, L.L.C. previously held 0 shares of ASND (ASCENDIS PHARMA A/S), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$209,034

Total Shares Change

-1,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$239.22
0
2025-Q4
Unchanged
1,400
0.0%
$298,5360.0%$209.34
0
2025-Q3
Unchanged
1,400
0.0%
$278,3340.0%$191.60
0
2025-Q2
Unchanged
1,400
0.0%
$241,6400.0%$172.22
0
2025-Q1
New
1,400
-
$218,2040.0%$154.68
32
2024-Q4
Exited
0
-100.0%
$00.0%$136.48
0
2024-Q3
New
1,400
-
$209,0340.0%$144.62
32

Other major holders of ASND: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used